Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 2—February 2004
2004 SARS Edition
Laboratory Study

Serologic and Molecular Biologic Methods for SARS-associated Coronavirus Infection, Taiwan

Ho-Sheng Wu*, Shu-Chun Chiu*, Tsan-Chang Tseng*, Szu-Fong Lin*, Jih-Hui Lin*, Yu-Fen Hsu*, Mei-Ching Wang*, Tsuey-Li Lin*, Wen-Zieh Yang*, Tian-Lin Ferng*, Kai-Hung Huang*, Li-Ching Hsu*, Li-Li Lee*, Jyh-Yuan Yang*, Hour-Young Chen*, Shun-Pi Su*, Shih-Yan Yang*, Ting-Hsiang Lin*, and Ih-Jen Su*Comments to Author 
Author affiliations: *Center for Disease Control, Department of Health, Taiwan, Republic of China

Main Article

Table 5

Laboratory confirmation rate in probable SARS cases, in combination of RT-PCR with different serologic methodsa

Results ELISA IFA Neutralization test ICT
PCR (+)
33.7% (158/469)
33.7% (158/469)
33.7% (158/469)
35.7% (87/244)
Antibody (+)
47.5% (223/469)
57.7% (252/469)
47.8% (224/469)
16.8% (41/244)
PCR (+) or antibody (+) 57.4% (269/469) 63.3% (297/469) 57.8% (271/469) 42.4% (103/244)

Main Article

Page created: January 26, 2011
Page updated: January 26, 2011
Page reviewed: January 26, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.